TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

Safety and Efficacy of a Novel Vaginal Anti-infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-blind, Phase 2, Controlled Trial.

Jeanne M Marrazzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.